Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

RxSight, Inc. - Common Stock (NQ:RXST)

9.730 +0.150 (+1.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
Forecasting The Future: 9 Analyst Projections For RxSight ↗
 
Via Benzinga
News headline image
Recap: RxSight Q4 Earnings ↗
 
Via Benzinga
News headline image
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From RxSight, Inc.
Via GlobeNewswire
News headline image
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 8 Takes On RxSight ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 28, 2024 ↗
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
News headline image
RxSight's Earnings Outlook ↗
 
Via Benzinga
News headline image
Breaking Down RxSight: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Analyst Expectations for RxSight's Future ↗
 
Via Benzinga
News headline image
RxSight: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Insiders are selling these hot stocks on track for higher prices
Insiders are selling these hot stocks and may cap gains in the near term, but long-term gains are in the outlook. Analysts support them and raise their targets. 
Via MarketBeat
News headline image
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky." 
Via Benzinga
News headline image
3 Stocks to Buy BEFORE They Become Household Names ↗
The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names. 
Via InvestorPlace
News headline image
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
From RxSight, Inc.
Via GlobeNewswire
News headline image
Where RxSight Stands With Analysts ↗
 
Via Benzinga
News headline image
RxSight's Earnings: A Preview ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for RxSight ↗
 
Via Benzinga
News headline image
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
News headline image
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. Reports Third Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. Educational and Product Announcements for AAO 2023
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
RxSight, Inc. Reports Second Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
From RxSight, Inc.
Via GlobeNewswire
News headline image
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+ ↗
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),  
Via Benzinga
News headline image
RxSight, Inc. Reports First Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.